Empirico
powering therapeutic discovery with human genetics and siRNA
San Diego, United States · $29.5M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Business Model
- B2B
- Website
- empiri.co
- Total Funding
- $29.5M
- Last Round
- $17.0M Series AJan 2020
- Rounds
- 2
About
Clinical-stage biotech developing siRNA medicines using human genetics-driven target discovery for common diseases with unmet need.
Summary
Empirico is a Biotech company based in San Diego, United States. It has raised $29.5M in total across 2 rounds, most recently a $17.0M Series A round in Jan 2020. Investors include Ionis Pharmaceuticals, DCVC (Data Collab) and NeoTribe Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.